Low HPV Vaccination Rates in UK; CBCD is not Concerned
The CBCD is not concerned about the low rate of HPV vaccination in UK since scientific studies of the HPV vaccine are inconclusive.
If your doctor belongs to our network of doctors, you are entitled to a discount. When ordering, please tell us the name of your doctor and we will check for you.
We accept all types of credit cards (credit, debit, pre-paid, etc.). Sorry, we don't accept other modes of payment.
We can also take your order over the phone. Call us if you would like to use this option.
To keep your privacy, your bank or credit card statements will only show the name of our parent company, not the product.
For your security, we will never call you and ask for your credit card number, or personal information.
See more details about Gene-Eden-VIR/Novirin in Package Insert.
Call us and ask about promotions
The Center for the Biology of Chronic
Disease (CBCD) has just learned that coverage for HPV vaccinations is not
comprehensive across all areas of the UK. Some areas seem to achieve a high
vaccination rate, while others seem to be falling behind.
The CBCD is not worried about this apparent
lack of comprehensive coverage and believes health officials and residents of
the UK should not be worried either.
The CBCD simply does not believe that the
science shows he the HPV Vaccine to be the best method of protection when
trying to guard the public against the virus that can cause some forms of
cancer as well as genital warts.
Gardasil, made by pharmaceutical giant,
Merck and Co., Inc., is intended to help prevent four strains of HPV - two
responsible for cervical cancer and two that cause genital warts - while
Cervarix, made by GSK, targets only the two cancer strains.
The difficulty the CBCD sees is that the
HPV vaccine only protects against four strains, yet there are 150 other types
of HPVs, at least 15 of which can cause cancer, and Gardasil provides no
protection against these other strains. 
Moreover, Merck's own studies demonstrate
that the vaccine is only effective for 5 years. Thus, if your 11 year old
daughter gets the vaccine, it will have stopped working by the time she is
16 ... right when she is actually at the highest danger of acquiring an HPV
Finally, the HPV vaccine is ineffective in
those who already have an HPV infection. Specifically, it will not get rid of
genital warts, and will not help a person who is already experiencing abnormal cervical cells
due to HPV.
This information is significant since there are no FDA approved treatments that get rid of the virus.
A healthy immune system is a person's best
defense against HPV caused diseases.
The good news is that the U.S.'s CDC says,
"In 90% of cases, the body's immune system clears HPV naturally within two
The CBCD would like to mention an HPV remedy that helps the immune system target the
"The key to your health is to reduce the
level of latent viruses in your body to harmless levels." - Dr. Hanan
The name of that HPV remedy is
Gene-Eden-VIR. It was scientifically designed to help the immune system
maintain a low concentration of the latent Human
Gene-Eden-VIR is was designed to target the latent Human Papillomavirus (HPV). Each ingredient was chosen through a
scientific approach. PolyDNA scientists scanned thousands of scientific and
medical papers published in various medical and scientific journals around the
world in order to identify safe and effective natural ingredients that
target the latent HPV.
Gene-Eden-VIR is safe. There
are no reports of side effects, and it has been on the market for over three
years. Each capsule contains a patented formula of five all natural
ingredients including selenium, camellia sinesis extract, quercetin,
cinnamomum extract, and licorice extract. In addition, each bottle is GMP
People can access the scientific
papers on the ingredients of Gene-Eden-VIR on
Gene-Eden-VIR is sold online through the
Gene-Eden website. Each bottle of Gene-Eden-VIR (a one
month's supply) costs $42.99.
Ordering Gene-Eden-VIR is
secure and confidential.
To learn more about Gene-Eden-VIR, the only
product on the market today that helps the body maintain low numbers of the
latent Human Papillomavirus (HPV), and that is scientifically backed by
published material, visit the Gene-Eden-VIR website.
 Human Papillomaviruses and Cancer,
National Cancer Institute, September 7, 2011,
 Haug CJ, Human Papillomavirus
Vaccination - Reasons for Caution, New England Journal of Medicine, August 21,
2008, 359; 861-862.
 Tomljenovic L and Shaw CA, Human
Papillomavirus (HPV) Vaccine Policy and Evidence-Based Medicine: Are They at
Odds? Annals of Medicine December 22, 2011;
Note: This press release was first issued by The Center for the
Biology of Chronic Disease (CBCD), a not-for-profit organization that specializes
in researching the biology of foreign DNA.